Easton Pharmaceuticals
121 articles about Easton Pharmaceuticals
-
Easton Pharmaceuticals Announces New Director / Officer to Its Board and Updates to Business Direction
6/20/2018
Easton Pharmaceuticals Inc. is pleased to announce a new director and officer to its board with the appointment of Mr. Vince Demasi of Alliance Group, as Chief Operating Officer & Director, and updates to business direction.
-
Easton Pharmaceuticals Announces That Easton and Its JV Partner, Alliance Group, Have Generated $40,000 in Revenues in the First Week of Operations
6/11/2018
Operations are Anticipated to Continually Increase, Which Includes Volume and Pricing, While it Prepares to Launch Its More Profitable Aggregate Operations
-
Easton Pharmaceuticals Announces Negotiations for a New Sub-Distribution Agreement for One of Its Woman’s Diagnostic / Treatment Products & Provides Update on Its Alliance Operations
2/6/2018
The company will transfer part of its licensed woman’s diagnostic and treatment products to another company including additional territories and provides update on its Alliance joint venture partnership.
-
Easton Pharmaceuticals Announces The Signing Of Closed Sub-Distribution Agreement for Product VS-Sense
1/25/2018
Agreement terms include several up-front cash payments based on milestones and a time limited recurring royalty payment on each product sold.
-
Easton Pharmaceuticals Announces the Appointment of Mr. Luigi Gentile as Director and Officer to the Company
1/10/2018
Luigi brings to Easton Pharmaceuticals a broad history of commercial leadership and innovation experience leading sales, marketing, product management and R&D teams in Healthcare
-
Easton Pharmaceuticals & Partner BMV Medica Announce Delivery and Launch of AmnioSense (AL-Sense) in Mexico; Delivery Date for Purchase Order From Windsor Pharmaceuticals for Central America
12/6/2017
Easton/BMV is also expecting delivery this week of initial Purchase Order for Central America with exclusive Distribution Partner, Windsor Pharmaceuticals, with launch in initial countries in Central America by February, 2018.
-
Easton Pharma / Alliance Group Awaits Equipment Delivery, Days Away From Commencing Operations on its Aggregate Contract After Closing $1.3M JV Agreement for 50% Property Ownership Interest and Various Business
11/28/2017
Once delivered, operations will commence which should then allow for additional contracts currently under negotiations to close.
-
Easton Pharmaceuticals Announces Final Payment Completing $1.3M JV Agreement With Alliance Group
10/23/2017
Easton has advanced its final payment, completing a total payment of $1.3 Million CDN to 1124123 Ontario Limited.
-
Easton Pharmaceuticals & JV Partner Alliance Group Announces It Has Cleared Final Hurdles Toward Allowing For The Cultivation Of Medical / Recreational Marijuana For National Canadian Market
10/10/2017
-
Easton Pharmaceuticals Announces That Its Partner Windsor Pharma Has Received Regulatory Approvals For Products VS-Sense And AL-Sense For Central America And The Caribbean
9/12/2017
-
Easton Pharmaceuticals Announces $1,000,000 Cdn In Payments Toward Alliance Group JV / Partnership Agreement; Announces $8,000,000 Cdn Aggregate LOI Contract
9/7/2017
-
Easton Pharmaceuticals And Alliance Group Announces The Closing Of Its First Aggregate Contract Valued At $6,000,000 CDN On Its 90 Acre Portion Of Industrial Zoned Land
8/23/2017
-
Easton Pharmaceuticals Announces Advancing $575,000 Payment Towards Closed Agreement With Alliance Group For The Cultivation Of Medical / Recreational Marijuana For Canada and Other Revenue Producing Businesses
8/16/2017
-
Easton Pharmaceuticals Announces Finalized Sub-Distribution Agreement With Gedeon Richter S.A.P.I De C.V. For Product Launch Of Amniosense (AL-Sense)
8/10/2017
-
Easton Pharmaceuticals Provides Shareholder Update On Acquisitions, Its Recent MMJ Initiative And Progress On Its Woman's Diagnostics And Treatment Segment
7/24/2017
-
Easton Pharmaceuticals Announces It Has Received $400,000 USD In Product Purchase Orders For The Current Quarter From Its Woman's Diagnostic And Treatment Products Business For The Mexico Market
6/27/2017
-
Easton Pharmaceuticals Announces It Has Finalized Agreement Terms With Alliance Group For Ownership Stake In Several Businesses On 45 Acres Of Agricultural Land, Which Includes The Cultivation Of Medical Marijuana For National Canadian Market
6/13/2017
-
Easton Pharmaceuticals Announces It Has Signed An LOI To Acquire An Interest In A 45 Acre Parcel For The Cultivation Of Medical Marijuana In Toronto, Canada; Wholly Owned Subsidiary, Ibliss In Birmingham's UK Vaper Expo
5/26/2017
-
Easton Pharmaceuticals Announces Formally Accepting Proposal For The Sub-Licensing Of Product VS-Sense From German Based Multi-National Pharmaceutical Company For Mexico; Agreement Includes An Up-Front Cash Payment And A Recurring Royalty
5/16/2017
-
Easton Pharmaceuticals Announces Signing LOI For The Acquisition Of Revenue Producing, Israel Based Therapeutics Company, Herbs Of Kedem
5/3/2017